These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock. Freeman BD; Yatsiv I; Natanson C; Solomon MA; Quezado ZM; Danner RL; Banks SM; Hoffman WD J Am Coll Surg; 1995 Mar; 180(3):286-92. PubMed ID: 7874338 [TBL] [Abstract][Full Text] [Related]
8. A controlled trial of HA-1A in a canine model of gram-negative septic shock. Quezado ZM; Natanson C; Alling DW; Banks SM; Koev CA; Elin RJ; Hosseini JM; Bacher JD; Danner RL; Hoffman WD JAMA; 1993 May; 269(17):2221-7. PubMed ID: 8474201 [TBL] [Abstract][Full Text] [Related]
9. The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels. Kumar A; Haery C; Paladugu B; Kumar A; Symeoneides S; Taiberg L; Osman J; Trenholme G; Opal SM; Goldfarb R; Parrillo JE J Infect Dis; 2006 Jan; 193(2):251-8. PubMed ID: 16362889 [TBL] [Abstract][Full Text] [Related]
10. A reconstituted, apolipoprotein A-I containing lipoprotein reduces tumor necrosis factor release and attenuates shock in endotoxemic rabbits. Hubsch AP; Powell FS; Lerch PG; Doran JE Circ Shock; 1993 May; 40(1):14-23. PubMed ID: 8324886 [TBL] [Abstract][Full Text] [Related]
11. Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock. Lechner AJ; Rouben LR; Potthoff LH; Tredway TL; Matuschak GM Circ Shock; 1993 Apr; 39(4):306-15. PubMed ID: 8485822 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy. Cubrilo-Turek M; Sertić J; Duraković Z Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019 [TBL] [Abstract][Full Text] [Related]
13. Lethal outcome caused by Porphyromonas gingivalis A7436 in a mouse chamber model is associated with elevated titers of host serum interferon-gamma. Huang JH; Lin YY; Lai YY; Hu SW Oral Microbiol Immunol; 2006 Apr; 21(2):100-6. PubMed ID: 16476019 [TBL] [Abstract][Full Text] [Related]
14. Increased survival of endotoxin-injected dogs treated with methylprednisolone, naloxone, and ibuprofen. Almqvist PM; Ekström B; Kuenzig M; Haglund U; Schwartz SI Circ Shock; 1984; 14(2):129-36. PubMed ID: 6509725 [TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidylcholine reduces the organ injury and dysfunction in rodent models of gram-negative and gram-positive shock. Murch O; Collin M; Sepodes B; Foster SJ; Mota-Filipe H; Thiemermann C Br J Pharmacol; 2006 Jul; 148(6):769-77. PubMed ID: 16751791 [TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
17. Endotoxin-induced mortality in bile duct-ligated rats after administration of reconstituted high-density lipoprotein. Sewnath ME; Levels HH; Oude Elferink R; van Noorden CJ; ten Kate FJ; van Deventer SJ; Gouma DJ Hepatology; 2000 Dec; 32(6):1289-99. PubMed ID: 11093736 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist. Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686 [TBL] [Abstract][Full Text] [Related]
20. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance. Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]